Hypertension is responsible for 7 million premature deaths yearly and 4.5% of the disease burden worldwide (64 million disability-adjusted life years). 1 Patients with essential hypertension have structural alterations of the precapillary arterioles that result from incompletely understood mechanisms triggered by baro-mechanical stress and impaired endothelial function. Th ese structural alterations are responsible, at least in part, for the increased peripheral resistance in this condition and are due to a combination of two processes: hypertrophic remodeling (encroachment of thickened media on the arteriolar lumen) and eutrophic remodeling (reduction of external diameter and lumen while the cross-sectional area of the media is unchanged). In both types, the medialumen (M:L) ratio of the resistance arterioles (<350 µm in diameter) is increased.
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Eutrophic remodeling, representing a rearrangement of the same amount of tissue around a smaller lumen, is predominant in spontaneously hypertensive rats and in humans with mild essential hypertension. Th is process results from a complex interplay of extracellular matrix components and adhesion molecules, apoptosis, and profi brotic and proinfl ammatory cytokines (reviewed by Intengan and Schiff rin 2 ). Th e renin-angiotensin system plays a pivotal role in the arteriolar remodeling, and previous studies have shown that angiotensin receptor type 1 (AT 1 ) blockers 3 and angiotensinconverting enzyme inhibitors 4 reduce the M:L ratio to a similar degree aft er 1 year of treatment.
In this issue, Gómez-Garre et al. 5 evaluate remodeling that focuses on the expression of cytokines in arterioles in gluteal subcutaneous biopsies of patients with essential hypertension. Th ey report that hypertensive patients had increased expression of connective tissue growth factor (CTGF), transforming growth factor-β (TGFβ), and collagens III and IV. In addition, they found that aft er 1 year of treatment, losartan prevented the increment of CTGF, TGFβ, and collagen III expression observed in amlodipinetreated patients with similar degrees of blood pressure control.
Th e investigation of local expression of cytokines and the evaluation of treatment with AT 1 receptor blockers are a logical consequence of the recognition that angio tensin II is a true cytokine that regulates cell growth and increases the production of extracellular matrix through its AT 1 receptors. Angiotensin II-induced profi brotic actions are mediated by both TGFβ and CTGF, 6, 7 and it is a reasonable assumption that improvement of arteriolar remodeling by angiotensin receptor blockade should be associated with the suppression of these cytokines.
Th e fi ndings of Gómez-Garre et al. 5 confi rm that losartan improves arteriolar lesions (that is, reduces the M:L ratio); however, this is accomplished without signifi cant reduction of TGFβ and CTGF expression. Amlodipine, in contrast, increases the expression of these cytokines and worsens remodeling (that is, increases the M:L ratio). Th erefore, the study fi ndings may be interpreted as supporting the preferential use of AT 1 receptor blockers in the treatment of essential hypertension. However, certain caveats must be taken into account. Th e arteriolar morphometry in this study was done in paraffi n-embedded biopsies, rather than in preparations of dissected arterioles mounted in an isometric myograph. As the authors recognize, the diff erence in technique was probably responsible for the fact that the external and internal (lumen) diameters and the medial crosssectional area that they report 5 were two to three times smaller than previously reported values in resistance arterioles obtained from subcutaneous gluteal biopsies. 3, 4 Similarly, the baseline M:L ratios in the present studies were about eight times higher than those obtained with vessels mounted on a pressurized myograph. Furthermore, the media width and media cross-sectional area in the amlodipine-treated group were signifi cantly reduced with therapy, despite an increment in the M:L ratio; this indicates that the low lumen diameter (the commentar y parameter more easily aff ected by the avoidance of myograph-assisted technique) was the determining factor in the increased M:L ratio values.
Nevertheless, the reduction observed in the M:L ratio was about 15%, reasonably close to the reduction of about 20% observed in other studies. 3 Unfortunately, the baseline (before-treatment) M:L ratio was significantly higher in the losartan-treated group than in the amlodipine-treated group (see Table 2 in Gómez-Garre et al. 5 ), and although it may be argued that the differences between losartan and amlodipine are even more remarkable because the former was applied to patients with more severe cases, comparison of the eff ects of two treatments on a given variable is diffi cult when the starting characteristics of the variable are not similar.
As noted by the authors 5 , CTGF, TGFβ, and collagen IV expressions were not reduced by losartan treatment; rather, this drug prevented the increase observed with amlodipine treatment. Interestingly, the expression of collagen III was reduced by both treatment schedules.
The villain role of amlodipine is, at least to me, somewhat unexpected, as in vitro studies have shown that amlodipine inhibits proliferation of vascular smooth muscle cells, 8 downregulates expression of collagens, and increases collagenase type IV activity. 9 Inasmuch as the spontaneous evolution of cytokine expression in the resistance arterioles of patients with well-controlled mild essential hypertension is unknown (it would be unethical to withhold antihypertensive treatment for 1 year), the conclusion that losartan prevented, or that amlodipine caused, an increment in cytokine expression is open to question. Nevertheless, this important study discloses discordant eff ects of two well-accepted treatments of essential hypertension on the structural changes of resistance arterioles. Taken together with previously reported investigations and recent clinical studies, 10 these results would speak in favor of the use of AT 1 receptor blockers in this condition and underline the need of further studies to defi ne the eff ects of antihypertensive drugs on arterial remodeling.
